IASLC

Applications are still open for two impactful STARS opportunities!

STARS Patient Research Advocate (PRA) Program – Virtual training for patients & caregivers
STARS Scholar Program – Join us in person at #WCLC26 with travel support

Learn more & apply by March 12, 2026
bit.ly/4qAlpz6

The IASLC Hot Topic Meeting returns this June, bringing together scientists, clinicians, and thought leaders to explore resistance to #immunotherapy in #lungcancer.
🗓️ Registration & abstracts open in March

Learn More: bit.ly/4rGmTc3

#HT26

Controversies in the Management of Lung Cancer: Comorbidities | IASLC In this episode of Lung Cancer Considered, host Dr. Narjust Florez explores controversies in managing lung cancer patients with comorbidities – those often un ...

In this new episode, Dr. Narjust Florez discusses managing lung cancer in patients with complex comorbidities with Dr. Hina Khan and Dr. Corey Langer, recorded at TTLC 2026.
Topics include ECOG PS2, renal dysfunction, advanced age, and individualized treatment decisions.
🎧 Stream now: bit.ly/4qWIDzy

📣 Call for #WCLC26 Pre-Conference Workshop Proposals – Deadline March 13, 2026

IASLC Members are invited to submit interactive workshop proposals for WCLC 2026 (Sat, Sept 12, Seoul).

Workshops must be 1.5–2 hrs. Share your expertise and engage the global community!

bit.ly/4cQDA0b

Radiotherapy Challenges in Locally Advanced Non-Small Cell Lung Cancer in the Neoadjuvant Era | IASLC Stage III NSCLC is now a moving target! This webinar will address key practice gaps and real-world decision points in the radiotherapy management of locally adv ...

Join us for an IASLC webinar!
This session will dive into practical radiotherapy strategies, staging insights, and multimodality care considerations for Stage III NSCLC.

Register here: bit.ly/4tLVFm7

#LungCancer #NSCLC #Oncology #Radiotherapy #MedicalEducation

In Brief for February 11, 2026 - ILCN.org (ILCN/WCLC) Nogapendekin alfa combination gains accelerated approval in Saudi Arabia for metastatic NSCLC.

New approval in metastatic NSCLC 👇

Nogapendekin alfa inbakicept combo therapy has gained accelerated approval in Saudi Arabia, marking another step in expanding treatment options globally.

Catch the full update in ILCN:
www.ilcn.org/in-brief-for...

#LCSM

Call for Talent - WCLC 2025 Join us at the IASLC 2026 World Conference on Lung Cancer (WCLC 2026) in Seoul, Republic of South Korea, from September 12–15, 2026.

🎤 #WCLC26 Call for Talent is open!

Heading to Seoul this September? Share your creative side; music, dance, poetry, instrumental performance & more at WCLC 2026.

Celebrate the global thoracic oncology community in a whole new way.

Submit your talent: bit.ly/46YcMY7

IASLC Spotlight: Q&A With the Education Committee Chair - ILCN.org (ILCN/WCLC) Committee Chair Dr. Ross Soo addresses its role in supporting the IASLC’s mission of providing relevant, impactful, and timely educational content on a global scale.

🌍 IASLC Spotlight: How does the Education Committee help advance IASLC’s global mission?

Dr. Ross Soo shares how the committee delivers timely, high-impact educational content that reaches clinicians and researchers worldwide.

Read the full feature in ILCN: bit.ly/4kGfLKC
#LCSM

Ready to share your work with the world? 🌎

Abstract submissions for #WCLC26 are officially open! Join the largest global meeting in lung & thoracic oncology and present your research on an international stage.

Submit today: bit.ly/4tqYxoz

#LungCancer #ThoracicOncology

🎧 Available now!

Dr. Steven Liu is joined by Dr. Raffaele Califano and Dr. Jessica Menis for a case-based discussion on extensive-stage SCLC, reviewing recent advances and how they inform treatment decisions today.

Listen here: bit.ly/461LUWN

#LungCancerConsidered #ThoracicOncology

What’s in store for #TTLC26? 🧬
The Conference Chairs share key programming highlights, breakthrough data to watch, and why this year’s meeting is one you won’t want to miss.

Get the preview in ILCN: bit.ly/3MoKSO4

#LCSM

LCC in Cantonese: Updates in Surgical Approaches and Techniques in Early-Stage Lung Cancer | IASLC As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Molly Li moderates a discussion in Cantonese with two expert card ...

🎧 New #LungCancerConsidered episode

Dr. Molly Li leads a conversation with Dr. Shuben Li and Dr. Calvin S.H. Ng on surgical management of early-stage #NSCLC, including VATS, resection approaches, endobronchial therapy, and tubeless anesthesia. Listen now: bit.ly/464OFGN
#GlobalOncology #LungCancer

📈 Lung cancer survival is improving, but too many are still diagnosed late, and access to screening & testing isn’t equal across communities. We can do better. Read the new national report from the American Lung Association: bit.ly/45ZPyR7

Join us for the #IASLC 2026 Hot Topic Meeting on Resistance to Immunotherapy!

🗓️ June 25-27, 2026
📍 Dublin, Ireland
👉 ht26-iaslc.eventsair.site/full-program

@iaslc.bsky.social @patrickforde.bsky.social

Will AI Take My Job? Discussing the Role of AI in Thoracic Oncology | IASLC This episode of Lung Cancer Considered takes an in-depth look at AI in lung cancer care. Join host Dr. Narjust Florez and Dr. Sandip Patel for a discussion of t ...

AI is rapidly changing the landscape of lung cancer care.
In the newest LCC episode, Dr. Narjust Florez speaks with Dr. @pateloncology.bsky.social about how AI is influencing patient care and experience, and the importance of staying informed as these tools evolve.

🎧 Listen here: bit.ly/3ZrrAKI

⏳ Regular registration closes tomorrow for the Targeted Therapies of Lung Cancer Conference (#TTLC26).

Join global experts to explore the latest data, practical strategies, and future directions in targeted lung cancer therapies.

🔗 Register now: www.ttlc-iaslc.org

Targeting NRG1 Fusions: A Potential Role for Zenocutuzumab as a First-Line Therapeutic Option - ILCN.org (ILCN/WCLC) Dr. Stephen Liu recently highlighted the safety and efficacy of a targeted therapy for patients with NRG1-positive cancers with updated data from the ongoing eNRGy trial.

New insights from Dr. Stephen Liu in ILCN spotlight zenocutuzumab as a potential first-line option for patients with NRG1-positive cancers.
Explore the article: bit.ly/3O1A09h

Stereotactic Radiosurgery for Established Brain Metastases: Prospective Evidence - ILCN.org (ILCN/WCLC) In the conclusion of this two-part series, Drs. Tomasik and Dziadziuszko highlight unresolved questions and future directions for integrating HA-PCI and SRS into practice for SCLC.

Tomasik and Dziadziuszko conclude their two-part ILCN series by highlighting unresolved clinical questions and future directions for integrating HA-PCI and SRS into SCLC practice. Essential reading for oncology care teams and researchers.
Read now: bit.ly/4qrMhRV

What’s next for clinical research? 🧬
#TTLC26 is counting down, bringing sharp minds together to talk targeted therapies and the future of the field.
bit.ly/3KP8GtL

Calling early & mid-career investigators in Asia-Pacific!

IASLC, in partnership with the Journal of Thoracic Oncology, will host a Reviewer Workshop at #WCLC26.

Participants receive:
✔️ Free WCLC registration
✔️ Travel & accommodation support
✔️ Additional benefits

🔗 Apply here: bit.ly/4a8DTk7

Looking for preclinical cancer model data?
VIKTOR is live and ready to use.

👉 www.iaslc.org/viktor

#PreclinicalModels #ResearchTools

Heading to #WCLC26?

We’re launching travel and education awards to support early career professionals, researchers in developing countries, nurses, allied health professionals, and patient advocates. Learn more & apply today: bit.ly/4qNoGfb

Managing complex #lungcancer cases takes true multidisciplinary coordination.

Join our Feb 26 #webinar to learn practical strategies for mediastinal staging, post-operative radiotherapy, and treatment sequencing after induction chemo-immunotherapy.

Register: bit.ly/4bqGS9G

Looking to exchange insights in thoracic oncology?

Thoracic Circle connects clinicians and researchers from around the world in one focused community.

Get started: bit.ly/491gZuc

The Importance of Compassion and Clear Communication: A Patient Advocate Perspective - ILCN.org (ILCN/WCLC) Patient advocate Kate Sinclair shares why communication is one of the most important tools for improving the patient experience during their lung cancer journey.

Patient advocate Kate Sinclair highlights the importance of compassion and clear communication in a new ILCN article.

Read her perspective now: bit.ly/49Fo303

In Brief for January 14, 2026 - ILCN.org (ILCN/WCLC) The US FDA grants special designation to risvutatug rezetecan for SCLC and approves the subcutaneous formulation of amivantamab plus hyaluronidase-lpuj for EGFR+ NSCLC.

📰 ICYMI: New updates from the US FDA for risvutatug rezetecan and the subcutaneous amivantamab plus hyaluronidase-lpuj.

Read the latest in ILCN: bit.ly/3YCZPP3

Discussão internacional sobre câncer de pulmão, em português!

This episode is part of IASLC’s Lung Cancer Considered World Language Series and focuses on the junior faculty perspective, hosted by Maria Cecilia Mathias with Maria Thereza Starling and Paula Duarte.

Listen now: bit.ly/Port-jfp

A Comprehensive Framework: Integrating Smoking Cessation into LCS - ILCN.org (ILCN/WCLC) Experts outline how Poland aims to reduce lung cancer mortality while addressing one of the nation’s most persistent health challenges: tobacco dependence.

Experts outline how #Poland aims to reduce #lungcancer mortality while addressing one of the nation’s most persistent health challenges: tobacco dependence.

Read more in ILCN: bit.ly/4qtSi1k

Modern Brain Radiotherapy in SCLC: Integrating Hippocampal Avoidance and Stereotactic Precision - ILCN.org (ILCN/WCLC) Drs. Tomasik and Dziadziuszko discuss how the SCLC field is shifting toward brain-sparing techniques to maximize disease control, as well as cognitive preservation.

Tomasik and Dziadziuszko highlight a shift in SCLC toward brain-sparing radiation that aims to improve disease control and protect cognitive function.

Explore their discussion on ILCN: bit.ly/4pB3esr

Complex lung cancer care demands real multidisciplinary coordination. Join our Feb 26 webinar to explore mediastinal staging, post-operative radiotherapy, and treatment sequencing after induction chemo-immunotherapy.
Learn practical strategies to close practice gaps.
Register: bit.ly/4bqGS9G